29 Jul 2023
7:43 am-9:30 am
Transcatheter aortic valve replacement (TAVR) part I
| Panelists: Aziz Ghaly, Ray Matthews, Firas Zahr | |
| DEBATE: TAVR-EMBOLIC PROTECTION DEVICES | |
| Case presentation | John Messenger, MD |
| The PROTECTED TAVR trial did not meet its primary endpoint, But the Sentinel EPD offers protection against major strokes | Raj Makkar, MD |
| Much has been learned from the Sentinel device but it’s time to apply lessons learned! | Giora Weisz, MD |
| Q&A | |
| UTILITY OF THE OPSENS SAVVYWIRE | |
| We should adopt universally: here is why! | Ruby Satpathy, MD |
| Here is what I need to adopt it universally! | Olcay Aksoy, MD |
| Q&A | |
| CORONARY PROTECTION | |
| Case presentation: I should have but did not! | Ashok Chaudhary, MD |
| Here is where we stand in 2023! | Homam Ibrahim, MD |
| Q&A | |
| DEBATE: HOW TO OPTIMIZE TAVR FOR VALVE-IN-VALVE PROCEDURES | |
| How I do it! – Sapien 3 valve: Case studies | Tarun Chakravarty, MD |
| How I do it! – Evolute Valve: Case studies | R. Michael Wyman, MD |
| Q&A | |
| DEBATE: TAVR PATIENT-PROSTHESIS MISMATCH: DOES IT REALLY MATTER? | |
| Of course, it matters! Here is why. | Firas Zahr, MD |
| It’s not “black and white”! Here is what we know! | Issam Moussa, MD |
| Q&A |